Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic Review

Background and Purpose: The availability of oncology biosimilars is deemed as a fundamental strategy to achieve sustainable health care. However, there is scarce systematic evidence on economic effectiveness of cancer biosimilars. We aimed to synthesize evidence from pharmacoeconomic evaluation of o...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hui-Yao, Liu, Cheng-Cheng, Yu, Yue, Wang, Le, Wu, Da-Wei, Guo, Lan-Wei, Wang, Shu-Hang, Fang, Hong, Bai, Ying, Fang, Yuan, Fan, Qi, Sun, Chao, Wu, Ying, Shi, Ju-Fang, Ma, Fei, Tang, Yu, Dai, Min, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849203/
https://www.ncbi.nlm.nih.gov/pubmed/33536905
http://dx.doi.org/10.3389/fphar.2020.572569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849203/
https://www.ncbi.nlm.nih.gov/pubmed/33536905
http://dx.doi.org/10.3389/fphar.2020.572569

Ejemplares similares